Zeltiq Aesthetics

About:

Zeltiq Aesthetics is a science-based medical device company developing non-invasive procedures for the reduction of unwanted fat tissue.

Website: http://zeltiq.com

Twitter/X: zeltiq

Top Investors: Frazier Healthcare Partners, Aisling Capital, Advanced Technology Ventures, Venrock

Description:

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.

Total Funding Amount:

$77.9M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2005-01-01

Contact Email:

support(AT)zeltiq.com

Founders:

Mitch Levinson, Scott J. Wolf

Number of Employees:

251-500

Last Funding Date:

2010-06-03

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai